Grossmann, Mathis <br/><br/>
Myostatin inhibition: a new treatment for androgen deprivation-induced sarcopenia?  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  Oct 2014 
 - 3625-8 p.  digital 
<br/><br/> Publication Type: Editorial; Research Support, Non-U.S. Gov't; Comment 
<br/><br/><label>ISSN: </label>1945-7197 
<br/><br/><label>Standard No.: </label>10.1210/jc.2014-3290  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgen Antagonists--adverse effects<br/>Body Mass Index<br/>Humans<br/>Immunoglobulin Fc Fragments--adverse effects<br/>Male<br/>Muscle, Skeletal--drug effects<br/>Myostatin--antagonists & inhibitors<br/>Prostatic Neoplasms--drug therapy<br/>Recombinant Fusion Proteins--adverse effects